4.7 Article

Disabled Homolog 2 Controls Prometastatic Activity of Tumor- Associated Macrophages

Journal

CANCER DISCOVERY
Volume 10, Issue 11, Pages 1758-1773

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-20-0036

Keywords

-

Categories

Funding

  1. V. Bronte grants of the Italian Association for Cancer Research [18603, 12182]
  2. Cancer Research Institute (Clinic and Laboratory Integration Program)
  3. Cariverona Foundation
  4. Qatar National Priority Research Program [NPRP11S-1211-170086]
  5. AIRC/FIRC fellowship
  6. Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG20583]
  7. Institutional funds of Universita Cattolica del Sacro Cuore (UCSC) [D1-2018/2019]
  8. Euronanomed III [723770]
  9. IOV 5 x 1000 Intramural Research Grant Project [BIGID219MARI]

Ask authors/readers for more resources

Tumor-associated macrophages (TAM) are regulators of extracellular matrix (ECM) remodeling and metastatic progression, the main cause of cancer-associated death. We found that disabled homolog 2 mitogen-responsive phosphoprotein (DAB2) is highly expressed in tumor-infiltrating TAMs and that its genetic ablation significantly impairs lung metastasis formation. DAB2-expressing TAMs, mainly localized along the tumor-invasive front, participate in integrin recycling, ECM remodeling, and directional migration in a tridimensional matrix. DAB2(+) macrophages escort the invasive dissemination of cancer cells by a mechanosensing pathway requiring the transcription factor YAP. In human lobular breast and gastric carcinomas, DAB2(+) TAMs correlated with a poor clinical outcome, identifying DAB2 as potential prognostic biomarker for stratification of patients with cancer. DAB2 is therefore central for the prometastatic activity of TAMs. SIGNIFICANCE: DAB2 expression in macrophages is essential for metastasis formation but not primary tumor growth. Mechanosensing cues, activating the complex YAP-TAZ, regulate DAB2 in macrophages, which in turn controls integrin recycling and ECM remodeling in 3-D tissue matrix. The presence of DAB2(+) TAMs in patients with cancer correlates with worse prognosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available